Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of K-755 in Healthy Volunteers
NCT03414294Phase 1Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Feb 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of K-755 (8 arms), sponsored by Kowa Company, Ltd. Primary endpoints: Incidence and severity of Adverse Events, Number of subjects with clinical laboratory test abnormalities and 3 more. Started Feb 2018; status: completed.
02
Drugs
K-755
Beyond the preview
Go deeper on NCT03414294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414294.